Bio-Gene Technology

Bio-Gene Technology P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Bio-Gene Technology (BGT.AX) as of Oct 22, 2026 is -4.88. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -3.72 — a change of 31.16% (lower).

P/CF

-4.88

YoY

31.16%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Bio-Gene Technology is 2026 -4.88 . P/CF (Price-to-Cash-Flow Ratio) of Bio-Gene Technology was 2025 -3.72 . It decreases by 31.16% lower compared to the previous year.

The Bio-Gene Technology P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2019
-4.30 AUD
Jan 1, 2020
-5.75 AUD
Jan 1, 2021
-5.18 AUD
Jan 1, 2022
217.32 AUD
Jan 1, 2023
-2.89 AUD
Jan 1, 2024
-3.43 AUD
Jan 1, 2025
-3.72 AUD
Jan 1, 2026
-4.88 AUD
The Bio-Gene Technology P/CF history
YEARP/CFYoY
-4.88+31.16%
-3.72+8.32%
-3.43+18.96%
-2.89-101.33%
217.32-4,295.16%
-5.18-9.91%
-5.75+33.85%
-4.30+7.81%
-3.98-69.28%
-12.97-42.49%
-22.55-69.73%
-74.49-62.53%
-198.81—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-Gene Technology Stock analysis

What does Bio-Gene Technology do? Bio-Gene Technology Ltd develops and commercializes insecticides using beta-triketone platform technology. The company's lead products are Flavocide, a chemically synthesized insecticide based on flavesone, and Qcide, a natural oil product containing tasmanone extracted from Gympie Messmate leaves via steam distillation. These products address insecticide resistance and toxicity issues in crop protection, storage, public health, animal health, and consumer applications. Insecticide manufacturers purchase the company's platform technology and products for commercialization across multiple sectors. The firm's beta-triketone platform provides multiple solutions for insecticide manufacturers seeking to develop novel pest control products. Flavocide and Qcide represent the company's primary commercial offerings, with Flavocide targeting synthetic insecticide markets and Qcide focusing on natural oil-based solutions. The company's technology enables the development of targeted insect control solutions for various applications including agricultural crop protection and public health management. Bio-Gene Technology Ltd. aims to develop a portfolio of targeted insect control solutions for insecticide manufacturers. The company's platform technology allows manufacturers to create new products addressing resistance and toxicity challenges. Through its two lead products, the company provides both synthetic and natural options for the insecticide market, targeting manufacturers who seek innovative solutions for pest management across different industry segments. Bio-Gene Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-Gene Technology stock

P/CF (Price-to-Cash-Flow Ratio) of Bio-Gene Technology is -4.88 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Bio-Gene Technology changed from -3.72 to -4.88, representing a 31.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Bio-Gene Technology since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Bio-Gene Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Bio-Gene Technology

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Bio-Gene Technology